General Information of Drug Inactive Ingredient (DIG) (ID: E00177)

DIG Name
Ethylparaben
Synonyms
Ethylparaben; ETHYL 4-HYDROXYBENZOATE; 120-47-8; Ethyl paraben; Ethyl p-hydroxybenzoate; Mycocten; 4-Hydroxybenzoic acid ethyl ester; Ethyl parasept; Ethyl parahydroxybenzoate; Easeptol; Ethyl butex; p-Hydroxybenzoic acid ethyl ester; Tegosept E; Napagin A; Nipagin A; Nipazin A; Solbrol A; Sobrol A; Benzoic acid, 4-hydroxy-, ethyl ester; p-Carbethoxyphenol; Aseptoform E; Mekkings E; Aseptin A; Bonomold OE; Ethyl p-oxybenzoate; Ethyl-p-hydroxybenzoate; Ethyl-4-hydroxybenzoate; Ethyl para-hydroxybenzoate; p-Oxybenzoesaeureaethylester; 4-Hydroxy-benzoic acid ethyl ester; 4-Carbethoxyphenol; NSC 23514; p-Hydroxybenzoate ethyl ester; Ethylparaben [NF]; UNII-14255EXE39; 4-Hydroxybenzoic acid, ethyl ester; 4-(Ethoxycarbonyl)phenol; Para-hydroxybenzoic acid ethyl ester; Ethylester kyseliny p-hydroxybenzoove; MFCD00002353; Benzoic acid, p-hydroxy-, ethyl ester; Ester etylowykwasu p-hydroksybenzoesowego; E214; Ethylparaben (NF); 14255EXE39; NCGC00160654-01; ethyl-paraben; Carbethoxyphenol; DSSTox_CID_2528; WLN: QR DVO2; DSSTox_RID_76615; DSSTox_GSID_22528; Ethyl 4-hydroxybenzoate, 99%; Caswell No. 447; p-Hydroxybenzoic acid, ethyl ester; CAS-120-47-8; HSDB 938; EINECS 204-399-4; p-Oxybenzoesaeureaethylester [German]; EPA Pesticide Chemical Code 061202; BRN 1101972; Ethyl chemosept; AI3-30960; Aseptine a; Nipagina A; Ethylester kyseliny p-hydroxybenzoove [Czech]; Ester etylowykwasu p-hydroksybenzoesowego [Polish]; PubChem20417; Ethyl 4-hydroxy-benzoate; Ethyl 4-hydroxyl-benzoate; Ethylparaben, INN, USAN; ACMC-209a7k; bmse010255; EC 204-399-4; p-Hydroxybenzoic ethyl ester; SCHEMBL28368; 4-10-00-00367 (Beilstein Handbook Reference); Ethyl 4-Hydroxybenzoate,(S); BIDD:ER0023; CHEMBL15841; Ethyl parahydroxybenzoate (TN); ZINC1392; DTXSID9022528; ethyl 4-hydroxybenzenecarboxylate; CHEBI:31575; 4-hydroxybenzoic acid-ethyl ester; AMY5118; NSC8510; Ethyl parahydroxybenzoate (JP17); ETHYL PARA HYDROXY BENZOATE; HMS2091E17; Parahydroxybenzoic acid ethyl ester; Pharmakon1600-01400151; 4-hydroxy benzoic acid ethyl ester; HY-B0934; NSC-8510; NSC23514; 4-(Dimethylamino)benzenesulfonicacid; Tox21_111961; Tox21_300335; ANW-17502; BBL012166; BDBM50428380; NSC-23514; NSC755851; s4525; SBB038536; STK070911; AKOS000120512; Tox21_111961_1; CCG-213682; CS-4403; DB13628; MCULE-4906467392; NSC-755851; NCGC00160654-02; NCGC00160654-03; NCGC00160654-04; NCGC00160654-06; NCGC00254462-01; AC-11586; AK-49315; AS-11988; NCI60_041866; SBI-0206674.P002; E-214; E0884; FT-0623514; FT-0626357; FT-0668364; ST50210582; 4-FLUORO-3-METHYLPHENYLMAGNESIUMBROMIDE; A16012; A18133; D01647; Ethyl 4-hydroxybenzoate, ReagentPlus(R), 99%; M-3934; AB00375765_03; 132597-EP2272843A1; 132597-EP2277881A1; 132597-EP2281817A1; 132597-EP2287155A1; 132597-EP2295414A1; 145754-EP2292234A1; 145754-EP2292611A1; 145754-EP2372017A1; Q229976; SR-05000001552; SR-05000001552-1; W-108475; BRD-K02464583-001-01-4; Ethyl 4-hydroxybenzoate, SAJ first grade, >=99.0%; Ethyl 4-hydroxybenzoate, Vetec(TM) reagent grade, 99%; Ethylparaben, certified reference material, TraceCERT(R); F0728-0009; UNII-AZF98361GV component NUVBSKCKDOMJSU-UHFFFAOYSA-N; 4-Hydroxybenzoic acid-ethyl ester 1000 microg/mL in Acetonitrile; Ethylparaben, United States Pharmacopeia (USP) Reference Standard; Ethyl parahydroxybenzoate, European Pharmacopoeia (EP) Reference Standard; Ethylparaben, Pharmaceutical Secondary Standard; Certified Reference Material; E4B
DIG Function
Antimicrobial preservative
Formula
C9H10O3
Canonical SMILES
CCOC(=O)C1=CC=C(C=C1)O
InChI
1S/C9H10O3/c1-2-12-9(11)7-3-5-8(10)6-4-7/h3-6,10H,2H2,1H3
InChIKey
NUVBSKCKDOMJSU-UHFFFAOYSA-N
Physicochemical Properties Molecular Weight 166.17 Topological Polar Surface Area 46.5
XlogP 2.5 Complexity 148
Heavy Atom Count 12 Rotatable Bond Count 3
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 3

Full List of Drug(s) Co-administrated with This DIG

2 Approved Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Clofazimine DMEBOFW Crohn disease [DD70] Clofazimine 100mg capsule F23118
Mirabegron DMS1GYT Overactive bladder [GC50.0] Mirabegron 8mg/ml extended release for suspension F23820
------------------